home
portfolio
approach
team
careers
news
contact
investor portal
home
portfolio
approach
team
careers
news
contact
investor portal
Nextech Invest
FLARE THERAPEUTICS TO PRESENT OVERVIEW OF CLINICAL CANDIDATE FX-909 AT AACR ANNUAL MEETING
FLARE THERAPEUTICS TO PRESENT OVERVIEW OF CLINICAL CANDIDATE FX-909 AT AACR ANNUAL MEETING
Post navigation
Previous Post
Previous
CULLINAN ONCOLOGY TO PRESENT NEW PRECLINICAL DATA FOR CLN-619 AND CLN-617 AT THE 2023 AMERICAN ASSOCIATION FOR CANCER RESEARCH ANNUAL MEETING
Next Post
Next
Kinnate Biopharma Inc. to Report First Clinical Data for Its Investigational Pan-RAF Inhibitor, Exarafenib (KIN-2787), in an Oral Presentation at the AACR 2023 Annual Meeting